Oncology
🇺🇸 FDA Page 6FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 61–72 of 246 articles
FDA Roundup: Oncology Drug Approvals in 2026
FDA Grants Dual Approval for T-DXd in HER2+ Early Breast Cancer
Bio-IT World Conference: Oncology Highlights - Day 1
Fierce Biotech Week: Key Takeaways and Emerging Trends
ASCO 2026 Oncology Drug Pipeline Preview
THMA Oncology Forum: Key Highlights and Emerging Trends
THMA Oncology Forum: Key Insights and Discussions
THMA Oncology Forum: Key Insights and Discussions Day 1
THMA Oncology Forum: Key Insights and Discussions Day 1
FDA Approves Guardant360 CDx Companion Diagnostic for Pfizer's VEPPANU in ER+/HER2- Breast Cancer
Alpha Tau's Alpha DaRT Achieves 100% Local Disease Control in Pancreatic Cancer Trials at DDW 2026
Alpha Tau's Alpha DaRT Achieves 100% Local Disease Control in Pancreatic Cancer Trials at DDW 2026